摘要
目的探讨布地奈德雾化吸入联合盐酸氨溴索静脉点滴辅治毛细支气管炎的临床疗效。方法将112例毛细支气管炎患儿随机分入对照组与观察组,给予52例对照组患儿抗感染、平喘等常规治疗,60例观察组患者接受布地奈德雾化吸入联合盐酸氨溴索静脉点滴治疗。比较两组临床疗效、临床症状体征消失时间、缺氧症状评分的差别。结果观察组与对照组治疗总有效率分别为98.3%和78.9%,差别具有统计学意义(P<0.05);观察组咳嗽、气促、肺部体征及X线征象消失时间均显著早于对照组(P<0.05);观察组治疗1d、3 d和5 d缺氧症状评分显著低于对照组(P<0.05)。结论布地奈德雾化吸入联合盐酸氨溴索静脉点滴辅治毛细支气管炎临床疗效更为理想,更有利于患儿病情恢复。
Objective To explore the effect of budesonide combined with ambroxol intravenous drip in adjunctive treatment of bronchioli tis. Methods A total of 112 cases with bronchiolitis were randomly divided into control group and experimental group. Fifty-two patients were given routine treatment including anti-infection and antiasthmatic. Sixty cases of experimental group received budesonide aerosol in halation combined with ambroxol intravenous drip. Clinical effect, disappearance time of clinical symptoms and signs and hypoxia symp toms scores were compared between two groups. Results The effective rates were 98.3% and 78.9% in experimental group and control group, respectively （ P 〈 O. 05 ）. The disappearance time of cough, anhelation, physical signs of lung and X-ray signs in experimental group were much earlier than those in control group （P 〈 O. 05 ）. The hypoxia symptoms scores on 1,3 and 5 days after treatment in experimen tal group were much lower than those in control group （ P 〈 O. 05 ）. Conclusions Budesonide combined with ambroxol intravenous drip for adjunctive treatment of bronchiolitis has better effect and is beneficial to faster recovery.
出处
《安徽医药》
CAS
2013年第10期1778-1779,共2页
Anhui Medical and Pharmaceutical Journal
